Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
It is not just artemisinin: .

Phytochemistry reviews : proceedings of the Phytochemical Society of Europe

Gruessner BM, Cornet-Vernet L, Desrosiers MR, Lutgen P, Towler MJ, Weathers PJ.
PMID: 33911989
Phytochem Rev. 2019 Dec;18(6):1509-1527. doi: 10.1007/s11101-019-09645-9. Epub 2019 Sep 19.

No abstract available.

Cite
Gruessner BM, Cornet-Vernet L, Desrosiers MR, et al. It is not just artemisinin: . Phytochem Rev. 2019;18(6):1509-1527doi: 10.1007/s11101-019-09645-9.
Gruessner, B. M., Cornet-Vernet, L., Desrosiers, M. R., Lutgen, P., Towler, M. J., & Weathers, P. J. (2019). It is not just artemisinin: . Phytochemistry reviews : proceedings of the Phytochemical Society of Europe, 18(6), 1509-1527. https://doi.org/10.1007/s11101-019-09645-9
Gruessner, B M, et al. "It is not just artemisinin: ." Phytochemistry reviews : proceedings of the Phytochemical Society of Europe vol. 18,6 (2019): 1509-1527. doi: https://doi.org/10.1007/s11101-019-09645-9
Gruessner BM, Cornet-Vernet L, Desrosiers MR, Lutgen P, Towler MJ, Weathers PJ. It is not just artemisinin: . Phytochem Rev. 2019 Dec;18(6):1509-1527. doi: 10.1007/s11101-019-09645-9. Epub 2019 Sep 19. PMID: 33911989; PMCID: PMC8078015.
Copy Download .nbib Format: NLM
Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis.

European journal of heart failure

Vidula MK, Orlenko A, Zhao L, Salvador L, Small AM, Horton E, Cohen JB, Adusumalli S, Denduluri S, Kobayashi T, Hyman M, Fiorilli P, Magro C, Singh B, Pourmussa B, Greczylo C, Basso M, Ebert C, Yarde M, Li Z, Cvijic ME, Wang Z, Walsh A, Maranville J, Kick E, Luettgen J, Adam L, Schafer P, Ramirez-Valle F, Seiffert D, Moore JH, Gordon D, Chirinos JA.
PMID: 34632675
Eur J Heart Fail. 2021 Oct 10; doi: 10.1002/ejhf.2361. Epub 2021 Oct 10.

AIMS: Enhanced risk stratification of patients with aortic stenosis (AS) is necessary to identify patients at high risk for adverse outcomes, and may allow for better management of patient subgroups at high risk of myocardial damage. The objective of...

Cite
Vidula MK, Orlenko A, Zhao L, et al. Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis. Eur J Heart Fail. 2021;doi: 10.1002/ejhf.2361.
Vidula, M. K., Orlenko, A., Zhao, L., Salvador, L., Small, A. M., Horton, E., Cohen, J. B., Adusumalli, S., Denduluri, S., Kobayashi, T., Hyman, M., Fiorilli, P., Magro, C., Singh, B., Pourmussa, B., Greczylo, C., Basso, M., Ebert, C., Yarde, M., Li, Z., Cvijic, M. E., Wang, Z., Walsh, A., Maranville, J., Kick, E., Luettgen, J., Adam, L., Schafer, P., Ramirez-Valle, F., Seiffert, D., Moore, J. H., Gordon, D., & Chirinos, J. A. (2021). Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis. European journal of heart failure, . https://doi.org/10.1002/ejhf.2361
Vidula, Mahesh K, et al. "Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis." European journal of heart failure vol. (2021). doi: https://doi.org/10.1002/ejhf.2361
Vidula MK, Orlenko A, Zhao L, Salvador L, Small AM, Horton E, Cohen JB, Adusumalli S, Denduluri S, Kobayashi T, Hyman M, Fiorilli P, Magro C, Singh B, Pourmussa B, Greczylo C, Basso M, Ebert C, Yarde M, Li Z, Cvijic ME, Wang Z, Walsh A, Maranville J, Kick E, Luettgen J, Adam L, Schafer P, Ramirez-Valle F, Seiffert D, Moore JH, Gordon D, Chirinos JA. Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis. Eur J Heart Fail. 2021 Oct 10; doi: 10.1002/ejhf.2361. Epub 2021 Oct 10. PMID: 34632675.
Copy Download .nbib Format: NLM
Artemisia plants, arachidonic and other polyunsaturated fatty acids.

MalariaWorld journal

Munyangi J, Lutgen P.
PMID: 34532222
Malariaworld J. 2020 Jun 01;11:3. eCollection 2020.

Arachidonic acid (AA or ARA) is an extremely important fatty acid involved in cell regulation. It is a polyunsaturated fatty acid (20:4n6) covalently bound in esterified form in membrane phospholipids of most body cells. Following irritation or injury, arachidonic...

Cite
Munyangi J, Lutgen P. Artemisia plants, arachidonic and other polyunsaturated fatty acids. Malariaworld J. 2020;11:3
Munyangi, J., & Lutgen, P. (2020). Artemisia plants, arachidonic and other polyunsaturated fatty acids. MalariaWorld journal, 113.
Munyangi, Jérôme, and Lutgen, Pierre. "Artemisia plants, arachidonic and other polyunsaturated fatty acids." MalariaWorld journal vol. 11 (2020): 3.
Munyangi J, Lutgen P. Artemisia plants, arachidonic and other polyunsaturated fatty acids. Malariaworld J. 2020 Jun 01;11:3. eCollection 2020. PMID: 34532222; PMCID: PMC8415067.
Copy Download .nbib Format: NLM
Dried-leaf .

World journal of pharmacology

Weathers PJ, Towler M, Hassanali A, Lutgen P, Engeu PO.
PMID: 25678989
World J Pharmacol. 2014 Dec 09;3(4):39-55. doi: 10.5497/wjp.v3.i4.39.

Artemisinin from the plant

Cite
Weathers PJ, Towler M, Hassanali A, et al. Dried-leaf . World J Pharmacol. 2014;3(4):39-55doi: 10.5497/wjp.v3.i4.39.
Weathers, P. J., Towler, M., Hassanali, A., Lutgen, P., & Engeu, P. O. (2014). Dried-leaf . World journal of pharmacology, 3(4), 39-55. https://doi.org/10.5497/wjp.v3.i4.39
Weathers, Pamela J, et al. "Dried-leaf ." World journal of pharmacology vol. 3,4 (2014): 39-55. doi: https://doi.org/10.5497/wjp.v3.i4.39
Weathers PJ, Towler M, Hassanali A, Lutgen P, Engeu PO. Dried-leaf . World J Pharmacol. 2014 Dec 09;3(4):39-55. doi: 10.5497/wjp.v3.i4.39. PMID: 25678989; PMCID: PMC4323188.
Copy Download .nbib Format: NLM
Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis.

European journal of heart failure

Vidula MK, Orlenko A, Zhao L, Salvador L, Small AM, Horton E, Cohen JB, Adusumalli S, Denduluri S, Kobayashi T, Hyman M, Fiorilli P, Magro C, Singh B, Pourmussa B, Greczylo C, Basso M, Ebert C, Yarde M, Li Z, Cvijic ME, Wang Z, Walsh A, Maranville J, Kick E, Luettgen J, Adam L, Schafer P, Ramirez-Valle F, Seiffert D, Moore JH, Gordon D, Chirinos JA.
PMID: 34632675
Eur J Heart Fail. 2021 Dec;23(12):2021-2032. doi: 10.1002/ejhf.2361. Epub 2021 Oct 21.

AIMS: Enhanced risk stratification of patients with aortic stenosis (AS) is necessary to identify patients at high risk for adverse outcomes, and may allow for better management of patient subgroups at high risk of myocardial damage. The objective of...

Cite
Vidula MK, Orlenko A, Zhao L, et al. Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis. Eur J Heart Fail. 2021;23(12):2021-2032doi: 10.1002/ejhf.2361.
Vidula, M. K., Orlenko, A., Zhao, L., Salvador, L., Small, A. M., Horton, E., Cohen, J. B., Adusumalli, S., Denduluri, S., Kobayashi, T., Hyman, M., Fiorilli, P., Magro, C., Singh, B., Pourmussa, B., Greczylo, C., Basso, M., Ebert, C., Yarde, M., Li, Z., Cvijic, M. E., Wang, Z., Walsh, A., Maranville, J., Kick, E., Luettgen, J., Adam, L., Schafer, P., Ramirez-Valle, F., Seiffert, D., Moore, J. H., Gordon, D., & Chirinos, J. A. (2021). Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis. European journal of heart failure, 23(12), 2021-2032. https://doi.org/10.1002/ejhf.2361
Vidula, Mahesh K, et al. "Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis." European journal of heart failure vol. 23,12 (2021): 2021-2032. doi: https://doi.org/10.1002/ejhf.2361
Vidula MK, Orlenko A, Zhao L, Salvador L, Small AM, Horton E, Cohen JB, Adusumalli S, Denduluri S, Kobayashi T, Hyman M, Fiorilli P, Magro C, Singh B, Pourmussa B, Greczylo C, Basso M, Ebert C, Yarde M, Li Z, Cvijic ME, Wang Z, Walsh A, Maranville J, Kick E, Luettgen J, Adam L, Schafer P, Ramirez-Valle F, Seiffert D, Moore JH, Gordon D, Chirinos JA. Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis. Eur J Heart Fail. 2021 Dec;23(12):2021-2032. doi: 10.1002/ejhf.2361. Epub 2021 Oct 21. PMID: 34632675.
Copy Download .nbib Format: NLM
Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient.

Frontiers in oncology

Phillips KG, Kolatkar A, Rees KJ, Rigg R, Marrinucci D, Luttgen M, Bethel K, Kuhn P, McCarty OJ.
PMID: 22934287
Front Oncol. 2012 Aug 09;2:96. doi: 10.3389/fonc.2012.00096. eCollection 2012.

Cancer metastasis, the leading cause of cancer-related deaths, is facilitated in part by the hematogenous transport of circulating tumor cells (CTCs) through the vasculature. Clinical studies have demonstrated that CTCs circulate in the blood of patients with metastatic disease...

Cite
Phillips KG, Kolatkar A, Rees KJ, et al. Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient. Front Oncol. 2012;2:96doi: 10.3389/fonc.2012.00096.
Phillips, K. G., Kolatkar, A., Rees, K. J., Rigg, R., Marrinucci, D., Luttgen, M., Bethel, K., Kuhn, P., & McCarty, O. J. (2012). Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient. Frontiers in oncology, 296. https://doi.org/10.3389/fonc.2012.00096
Phillips, Kevin G, et al. "Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient." Frontiers in oncology vol. 2 (2012): 96. doi: https://doi.org/10.3389/fonc.2012.00096
Phillips KG, Kolatkar A, Rees KJ, Rigg R, Marrinucci D, Luttgen M, Bethel K, Kuhn P, McCarty OJ. Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient. Front Oncol. 2012 Aug 09;2:96. doi: 10.3389/fonc.2012.00096. eCollection 2012. PMID: 22934287; PMCID: PMC3414893.
Copy Download .nbib Format: NLM
First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor.

Clinical and translational science

Perera V, Wang Z, Luettgen J, Li D, DeSouza M, Cerra M, Seiffert D.
PMID: 34558200
Clin Transl Sci. 2021 Sep 24; doi: 10.1111/cts.13148. Epub 2021 Sep 24.

Milvexian (BMS-986177/JNJ-70033093) is a small molecule, active-site inhibitor of factor XIa (FXIa) being developed to prevent and treat thrombotic events. The safety, tolerability, pharmacokinetics (PKs), and pharmacodynamics (PDs) of milvexian were assessed in a two-part, double-blind, placebo-controlled, sequential single...

Cite
Perera V, Wang Z, Luettgen J, et al. First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor. Clin Transl Sci. 2021;doi: 10.1111/cts.13148.
Perera, V., Wang, Z., Luettgen, J., Li, D., DeSouza, M., Cerra, M., & Seiffert, D. (2021). First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor. Clinical and translational science, . https://doi.org/10.1111/cts.13148
Perera, Vidya, et al. "First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor." Clinical and translational science vol. (2021). doi: https://doi.org/10.1111/cts.13148
Perera V, Wang Z, Luettgen J, Li D, DeSouza M, Cerra M, Seiffert D. First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor. Clin Transl Sci. 2021 Sep 24; doi: 10.1111/cts.13148. Epub 2021 Sep 24. PMID: 34558200.
Copy Download .nbib Format: NLM
Resolving the relative contributions of cistern and pour flushing to toilet water usage: Measurements from urban test sites in India.

The Science of the total environment

Welling CM, Varigala S, Krishnaswamy S, Raj A, Lynch B, Piascik JR, Stoner BR, Hawkins BT, Hegarty-Craver M, Luettgen MJ, Grego S.
PMID: 32402964
Sci Total Environ. 2020 Aug 15;730:138957. doi: 10.1016/j.scitotenv.2020.138957. Epub 2020 Apr 25.

A challenge in water reuse for toilet flushing in India and other Asian countries derives from pour flushing practices. It is a common assumption that the amount of pour flushed water used for personal cleansing is small in comparison...

Cite
Welling CM, Varigala S, Krishnaswamy S, et al. Resolving the relative contributions of cistern and pour flushing to toilet water usage: Measurements from urban test sites in India. Sci Total Environ. 2020;730:138957doi: 10.1016/j.scitotenv.2020.138957.
Welling, C. M., Varigala, S., Krishnaswamy, S., Raj, A., Lynch, B., Piascik, J. R., Stoner, B. R., Hawkins, B. T., Hegarty-Craver, M., Luettgen, M. J., & Grego, S. (2020). Resolving the relative contributions of cistern and pour flushing to toilet water usage: Measurements from urban test sites in India. The Science of the total environment, 730138957. https://doi.org/10.1016/j.scitotenv.2020.138957
Welling, Claire M, et al. "Resolving the relative contributions of cistern and pour flushing to toilet water usage: Measurements from urban test sites in India." The Science of the total environment vol. 730 (2020): 138957. doi: https://doi.org/10.1016/j.scitotenv.2020.138957
Welling CM, Varigala S, Krishnaswamy S, Raj A, Lynch B, Piascik JR, Stoner BR, Hawkins BT, Hegarty-Craver M, Luettgen MJ, Grego S. Resolving the relative contributions of cistern and pour flushing to toilet water usage: Measurements from urban test sites in India. Sci Total Environ. 2020 Aug 15;730:138957. doi: 10.1016/j.scitotenv.2020.138957. Epub 2020 Apr 25. PMID: 32402964; PMCID: PMC7272130.
Copy Download .nbib Format: NLM
Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient.

Frontiers in oncology

Phillips KG, Velasco CR, Li J, Kolatkar A, Luttgen M, Bethel K, Duggan B, Kuhn P, McCarty OJ.
PMID: 22826822
Front Oncol. 2012 Jul 18;2:72. doi: 10.3389/fonc.2012.00072. eCollection 2012.

Clinical studies have demonstrated that circulating tumor cells (CTCs) are present in the blood of cancer patients with known metastatic disease across the major types of epithelial malignancies. Recent studies have shown that the concentration of CTCs in the...

Cite
Phillips KG, Velasco CR, Li J, et al. Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient. Front Oncol. 2012;2:72doi: 10.3389/fonc.2012.00072.
Phillips, K. G., Velasco, C. R., Li, J., Kolatkar, A., Luttgen, M., Bethel, K., Duggan, B., Kuhn, P., & McCarty, O. J. (2012). Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient. Frontiers in oncology, 272. https://doi.org/10.3389/fonc.2012.00072
Phillips, Kevin G, et al. "Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient." Frontiers in oncology vol. 2 (2012): 72. doi: https://doi.org/10.3389/fonc.2012.00072
Phillips KG, Velasco CR, Li J, Kolatkar A, Luttgen M, Bethel K, Duggan B, Kuhn P, McCarty OJ. Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient. Front Oncol. 2012 Jul 18;2:72. doi: 10.3389/fonc.2012.00072. eCollection 2012. PMID: 22826822; PMCID: PMC3399133.
Copy Download .nbib Format: NLM
Survival of IVF-derived bovine embryos frozen in glycerol or ethylene glycol.

Theriogenology

Hasler JF, Hurtgen PJ, Jin ZQ, Stokes JE.
PMID: 16728153
Theriogenology. 1997 Sep;48(4):563-79. doi: 10.1016/s0093-691x(97)00274-4.

Survival of IVF-derived bovine embryos of different ages and stages of development, produced in 2 different co-culture systems and frozen in 2 different cryoprotectants, was investigated. In vitro-derived bovine embryos (n = 5,525) were utilized to study survival following...

Cite
Hasler JF, Hurtgen PJ, Jin ZQ, et al. Survival of IVF-derived bovine embryos frozen in glycerol or ethylene glycol. Theriogenology. 1997;48(4):563-79doi: 10.1016/s0093-691x(97)00274-4.
Hasler, J. F., Hurtgen, P. J., Jin, Z. Q., & Stokes, J. E. (1997). Survival of IVF-derived bovine embryos frozen in glycerol or ethylene glycol. Theriogenology, 48(4), 563-79. https://doi.org/10.1016/s0093-691x(97)00274-4
Hasler, J F, et al. "Survival of IVF-derived bovine embryos frozen in glycerol or ethylene glycol." Theriogenology vol. 48,4 (1997): 563-79. doi: https://doi.org/10.1016/s0093-691x(97)00274-4
Hasler JF, Hurtgen PJ, Jin ZQ, Stokes JE. Survival of IVF-derived bovine embryos frozen in glycerol or ethylene glycol. Theriogenology. 1997 Sep;48(4):563-79. doi: 10.1016/s0093-691x(97)00274-4. PMID: 16728153.
Copy Download .nbib Format: NLM
Retraction notice to "Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial." [PHYTOMEDICINE 51C (2018) 233-240].

Phytomedicine : international journal of phytotherapy and phytopharmacology

Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P.
PMID: 32972796
Phytomedicine. 2020 Nov;78:153303. doi: 10.1016/j.phymed.2020.153303. Epub 2020 Sep 22.

No abstract available.

Cite
Munyangi J, Cornet-Vernet L, Idumbo M, et al. Retraction notice to "Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial." [PHYTOMEDICINE 51C (2018) 233-240]. Phytomedicine. 2020;78:153303doi: 10.1016/j.phymed.2020.153303.
Munyangi, J., Cornet-Vernet, L., Idumbo, M., Lu, C., Lutgen, P., Perronne, C., Ngombe, N., Bianga, J., Mupenda, B., Lalukala, P., Mergeai, G., Mumba, D., Towler, M., & Weathers, P. (2020). Retraction notice to "Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial." [PHYTOMEDICINE 51C (2018) 233-240]. Phytomedicine : international journal of phytotherapy and phytopharmacology, 78153303. https://doi.org/10.1016/j.phymed.2020.153303
Munyangi, Jérôme, et al. "Retraction notice to "Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial." [PHYTOMEDICINE 51C (2018) 233-240]." Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 78 (2020): 153303. doi: https://doi.org/10.1016/j.phymed.2020.153303
Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P. Retraction notice to "Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial." [PHYTOMEDICINE 51C (2018) 233-240]. Phytomedicine. 2020 Nov;78:153303. doi: 10.1016/j.phymed.2020.153303. Epub 2020 Sep 22. PMID: 32972796; PMCID: PMC7751617.
Copy Download .nbib Format: NLM
Retraction notice to <"Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial"> <[PHYTOMEDICINE 57C (2019) 49-56]>.

Phytomedicine : international journal of phytotherapy and phytopharmacology

Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P.
PMID: 32972797
Phytomedicine. 2020 Nov;78:153304. doi: 10.1016/j.phymed.2020.153304. Epub 2020 Sep 21.

No abstract available.

Cite
Munyangi J, Cornet-Vernet L, Idumbo M, et al. Retraction notice to <"Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial"> <[PHYTOMEDICINE 57C (2019) 49-56]>. Phytomedicine. 2020;78:153304doi: 10.1016/j.phymed.2020.153304.
Munyangi, J., Cornet-Vernet, L., Idumbo, M., Lu, C., Lutgen, P., Perronne, C., Ngombe, N., Bianga, J., Mupenda, B., Lalukala, P., Mergeai, G., Mumba, D., Towler, M., & Weathers, P. (2020). Retraction notice to <"Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial"> <[PHYTOMEDICINE 57C (2019) 49-56]>. Phytomedicine : international journal of phytotherapy and phytopharmacology, 78153304. https://doi.org/10.1016/j.phymed.2020.153304
Munyangi, Jérôme, et al. "Retraction notice to <"Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial"> <[PHYTOMEDICINE 57C (2019) 49-56]>." Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 78 (2020): 153304. doi: https://doi.org/10.1016/j.phymed.2020.153304
Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P. Retraction notice to <"Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial"> <[PHYTOMEDICINE 57C (2019) 49-56]>. Phytomedicine. 2020 Nov;78:153304. doi: 10.1016/j.phymed.2020.153304. Epub 2020 Sep 21. PMID: 32972797; PMCID: PMC7751478.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries